Skip to main content
Founded in Jaipur in 1998 · Physician-directed Ayurvedic care
Traditional Ayurvedic Joint & Vata Support

Simhanada Guggul Vati

Simhanada Guggul Vati is a classical Ayurvedic Guggulu formulation traditionally used in Ama Vata patterns, particularly when joint stiffness, swelling and digestive sluggishness occur together.

Price
₹2,015.25
Pack size: 90 Vati
Available to order
Quantity
1
Product form
Tablet / Vati
Pack size
90 Vati
Route
Oral
Approx. weight per Vati
500 mg
Questions about dosing or compatibility? Write to our pharmacy team

Overview

Simhanada Guggul Vati combines purified Guggulu, Triphala and Eranda (castor) oil in a traditional Ayurvedic formulation. It is used as supportive care when joint discomfort and stiffness are associated with sluggish digestion and the accumulation of Ama.

The formulation brings together ingredients traditionally valued for supporting digestion, healthy Vata movement and comfortable joint function.

Traditional Ayurvedic Perspective

In Ayurveda, Amavata is understood in relation to impaired digestion, Ama and disturbed Vata, with symptoms that may include joint stiffness, swelling and discomfort.

Simhanada Guggul is traditionally used with this understanding, supporting Agni, Ama management and Vata balance. Its use is generally considered according to the individual’s digestion, symptoms, strength and overall Ayurvedic assessment.

Ayurvedic Actions

Deepana / Pachana
Supports digestive strength and the proper processing of Ama.
Shothahara
Supports healthy inflammatory balance and helps maintain joint comfort.
Vatanulomana
Supports the natural movement and balance of Vata.

Traditionally Used To Support

  • Healthy joint function and mobility
  • Maintain comfortable movement
  • When joint stiffness and swelling are associated with Ama-Vata
  • Digestion and healthy metabolism
  • Balanced Vata function

Composition

  • Purified Guggulu
  • Triphala
  • Haritaki
  • Bibhitaki
  • Amalaki
  • Eranda Taila (Castor oil)

Botanical Profile

Guggulu

Botanical name
Commiphora wightii
Family
Burseraceae
Common name
Guggulu / Indian Bdellium
Part used
Oleo-gum-resin
Preparation
Purified before use

Haritaki

Botanical name
Terminalia chebula
Family
Combretaceae
Common name
Haritaki / Chebulic Myrobalan
Part used
Fruit

Bibhitaki

Botanical name
Terminalia bellirica
Family
Combretaceae
Common name
Bibhitaki / Baheda
Part used
Fruit

Amalaki

Botanical name
Phyllanthus emblica
Family
Phyllanthaceae
Common name
Amalaki / Amla / Indian Gooseberry
Part used
Fruit

Eranda

Botanical name
Ricinus communis
Family
Euphorbiaceae
Common name
Castor
Part used
Oil from the seed

Suggested Dosage

Two tablets twice or three times daily, or as directed by an Ayurvedic physician.

Storage

Store in a cool, dry place away from direct sunlight and moisture.

Keep the container tightly closed after use.

Keep out of reach of children.

Ayurveda References

Official formulary reference

Formulary of Ayurvedic Medicines of CGHS

Government of India, 2015 — Serial No. 140, Singhnad Guggulu

The formulation is listed in the Government of India’s CGHS Ayurvedic formulary under the Singhnad Guggulu lineage. (Chakrapani Ayurveda)

View the official CGHS Ayurvedic formulary

Official pharmacopoeial standard

The Ayurvedic Pharmacopoeia of India

API Part I, Vol. I — Guggulu (Exudate)

Identifies Guggulu as the medicinal exudate of Commiphora wightii and provides official standards for the raw drug. (Chakrapani Ayurveda)

View the official PCIM&H catalogue

Official pharmacopoeial standards

Haritaki, Bibhitaki & Amalaki

The Ayurvedic Pharmacopoeia of India provides individual monographs for the three fruits that constitute Triphala. (Chakrapani Ayurveda)

View the official PCIM&H catalogue

Research Highlights

Clinical Efficacy of Simhanada Guggulu in Amavata

Randomized comparative human study · 24 patients · 8 weeks

Preparation and Dose

Participants received Simhanada Guggulu at 6 g per day in divided doses for eight weeks. A comparator group received Shiva Guggulu at the same daily dose. (PubMed)

Finding

The study reported improvement in symptoms of Amavata, with the Simhanada Guggulu group showing greater overall improvement than the comparator group.

The study was small and non-blinded, and it evaluated Simhanada Guggulu as a formulation. The findings should therefore be considered supportive clinical evidence rather than definitive proof of effectiveness.

Reference

Pandey SA, Joshi NP, Pandya DM.

Clinical efficacy of Shiva Guggulu and Simhanada Guggulu in Amavata (Rheumatoid Arthritis).

AYU. 2012;33(2):247–254.

PMID: 23559798

DOI: 10.4103/0974-8520.105246

View this study on PubMed

Comparative Clinical Study

A separate clinical study involving 101 patients compared Simhanada Guggulu with Rasona Rasnadi Ghanavati in Amavata. Both groups showed significant improvement in symptoms, although the Rasona Rasnadi group showed better overall results in that study. (PubMed)

Reference

Mahto RR, Dave AR, Shukla VD.

A comparative study of Rasona Rasnadi Ghanavati and Simhanada Guggulu on Amavata with special reference to rheumatoid arthritis.

AYU. 2011;32(1):46–54.

PMID: 22131757

DOI: 10.4103/0974-8520.85724

View this study on PubMed

Other preparations in vati and tablets.